Cargando…
Treatment of Human Urinary Kallidinogenase Combined with Maixuekang Capsule Promotes Good Functional Outcome in Ischemic Stroke
Aims: To evaluate the clinical efficacy of Human Urinary Kallidinogenase (HUK) and Maixuekang capsule in the treatment of acute ischemic stroke (AIS) patients. Methods: In this study, from January 2016 to July 2016, 60 patients with acute ischemic stroke were enrolled and 56 patients with complete i...
Autores principales: | Song, Juexian, Lyu, Yi, Wang, Miaomiao, Zhang, Jing, Gao, Li, Tong, Xiaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816573/ https://www.ncbi.nlm.nih.gov/pubmed/29487537 http://dx.doi.org/10.3389/fphys.2018.00084 |
Ejemplares similares
-
Human Urinary kallidinogenase promotes good recovery in ischemic stroke patients with level 3 hypertension
por: Wu, Danhong, et al.
Publicado: (2017) -
Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke
por: Qian, Yun, et al.
Publicado: (2019) -
Human Urinary Kallidinogenase decreases recurrence risk and promotes good recovery
por: Han, Dong, et al.
Publicado: (2018) -
Sanhuang Xiexin decoction promotes good functional outcome in acute ischemic stroke
por: Song, Juexian, et al.
Publicado: (2018) -
Human urinary kallidinogenase combined with edaravone in treating acute ischemic stroke patients: A meta‐analysis
por: Yang, Di‐Xiao, et al.
Publicado: (2021)